They have done a fantastic job Salt ...but "shortly" doesn't...

First 69 Last

Share
Profile

Follow
sirjohnnyboy

2,599 Posts.

1713

05/03/18

11:19

Post #: 31525369
Share

Originally posted by Saltiga62 ↑

G'day SJB-Buyer depth ratio at 2 1/2-01 in favour of buyers -12.5 mil traded in 35
minutes.
I don't think the term delayed can be utilised as their was never an absolute fixed
date used as datum point-so nothing can be referred to as delayed.
There will have been a tonnage objective -through-put targeted objective set
& any number of variables can come into play pursuing the objective set
hence what else can the company say to market.
They can say nothing at all -then the market gets anxious waiting.
They can have a fixed date & if issues delay tonnage objectives the market gets anxious.
The fact they have used the word shortly strong implies confidence imo.

Many other juniors will leave investors hanging on awaited Ann for months !
Allowing for only having single shift operations & a small MGT team I am actually
quiet astounded by progress & Ann frequency thus far.
Current share price is saying all that needs to be said.
imo-gltah
salt

Expand

They have done a fantastic job Salt ...but "shortly" doesn't mean a week.

Drag a better word out of the lexicon or a more accurate description.

I'm sure it wasn't intentional (and it's not the end of the world) ...but best not to paint ourselves into a corner by poor word choice.

After a tumultuous ride and a leap of faith at 2c ...I'm finally tens of thousands up on my original investment -so no complaints about the company performance from me.

Someone used "tears of joy" recently ...springs to mind

Cheers,

SJB

Last edited by sirjohnnyboy: 05/03/18

OGX Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
13 Upvote

1 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 57 more messages in this thread...

First 69 Last

Add OGX (ASX) to my watchlist

They have done a fantastic job Salt ...but "shortly" doesn't...

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News